PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSMUSG00000030067.18 | Foxp1 |
Foxj2
|
ENSMUSG00000003154.16 | Foxj2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp1 | mm39_v1_chr6_-_99498112_99498128 | 0.30 | 1.1e-02 | Click! |
Foxj2 | mm39_v1_chr6_+_122803624_122803640 | 0.20 | 1.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_52151026 | 12.59 |
ENSMUST00000228164.2
|
Ndrg2
|
N-myc downstream regulated gene 2 |
chr14_-_52150804 | 11.83 |
ENSMUST00000004673.15
ENSMUST00000111632.5 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr14_-_52151537 | 10.79 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr6_-_58884038 | 9.81 |
ENSMUST00000059539.5
|
Nap1l5
|
nucleosome assembly protein 1-like 5 |
chr3_+_106020545 | 9.05 |
ENSMUST00000079132.12
ENSMUST00000139086.2 |
Chia1
|
chitinase, acidic 1 |
chr1_+_171052623 | 8.80 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr14_+_14210932 | 8.72 |
ENSMUST00000022271.14
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr5_+_14075281 | 8.38 |
ENSMUST00000073957.8
|
Sema3e
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
chr16_+_22739028 | 7.85 |
ENSMUST00000232097.2
|
Fetub
|
fetuin beta |
chr12_-_11485639 | 7.42 |
ENSMUST00000220506.2
|
Vsnl1
|
visinin-like 1 |
chr2_-_57942844 | 7.38 |
ENSMUST00000090940.6
|
Ermn
|
ermin, ERM-like protein |
chr2_+_67948057 | 7.31 |
ENSMUST00000112346.3
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr16_+_22738987 | 7.21 |
ENSMUST00000023587.12
|
Fetub
|
fetuin beta |
chr16_-_34083549 | 7.14 |
ENSMUST00000114949.8
ENSMUST00000114954.8 |
Kalrn
|
kalirin, RhoGEF kinase |
chr19_-_38113696 | 6.86 |
ENSMUST00000025951.14
ENSMUST00000237287.2 |
Rbp4
|
retinol binding protein 4, plasma |
chr2_+_14878480 | 6.85 |
ENSMUST00000114719.7
|
Cacnb2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr2_-_65194344 | 6.82 |
ENSMUST00000155962.3
ENSMUST00000112420.8 ENSMUST00000152324.8 |
Slc38a11
|
solute carrier family 38, member 11 |
chr11_+_69945157 | 6.71 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr16_-_34083315 | 6.66 |
ENSMUST00000114953.8
|
Kalrn
|
kalirin, RhoGEF kinase |
chr16_+_22739191 | 6.44 |
ENSMUST00000116625.10
|
Fetub
|
fetuin beta |
chr10_+_59942274 | 6.37 |
ENSMUST00000165024.3
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr5_-_145816774 | 6.28 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr4_-_15149755 | 6.28 |
ENSMUST00000108273.2
|
Necab1
|
N-terminal EF-hand calcium binding protein 1 |
chr11_+_89921121 | 6.25 |
ENSMUST00000092788.4
|
Tmem100
|
transmembrane protein 100 |
chr14_-_45715308 | 6.21 |
ENSMUST00000141424.2
|
Fermt2
|
fermitin family member 2 |
chr1_-_87501548 | 6.13 |
ENSMUST00000068681.12
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr9_+_75213570 | 6.10 |
ENSMUST00000213990.2
|
Gnb5
|
guanine nucleotide binding protein (G protein), beta 5 |
chr8_+_31581635 | 6.08 |
ENSMUST00000161713.2
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr4_+_94627755 | 6.04 |
ENSMUST00000071168.6
|
Tek
|
TEK receptor tyrosine kinase |
chr18_-_12429048 | 5.94 |
ENSMUST00000234212.2
|
Ankrd29
|
ankyrin repeat domain 29 |
chr19_-_43974990 | 5.85 |
ENSMUST00000026210.5
|
Cpn1
|
carboxypeptidase N, polypeptide 1 |
chr10_+_112292161 | 5.74 |
ENSMUST00000219607.2
ENSMUST00000218827.2 |
Kcnc2
|
potassium voltage gated channel, Shaw-related subfamily, member 2 |
chr2_+_126398048 | 5.61 |
ENSMUST00000141482.3
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr15_-_12549350 | 5.56 |
ENSMUST00000190929.2
|
Pdzd2
|
PDZ domain containing 2 |
chr11_+_108286114 | 5.55 |
ENSMUST00000000049.6
|
Apoh
|
apolipoprotein H |
chr3_+_129326004 | 5.54 |
ENSMUST00000199910.5
ENSMUST00000197070.5 ENSMUST00000071402.7 |
Elovl6
|
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
chr9_-_121745354 | 5.51 |
ENSMUST00000062474.5
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr5_+_146321757 | 5.47 |
ENSMUST00000016143.9
|
Wasf3
|
WASP family, member 3 |
chr13_-_4200627 | 5.47 |
ENSMUST00000110704.9
ENSMUST00000021635.9 |
Akr1c18
|
aldo-keto reductase family 1, member C18 |
chr12_-_11486544 | 5.47 |
ENSMUST00000072299.7
|
Vsnl1
|
visinin-like 1 |
chr2_-_73605387 | 5.33 |
ENSMUST00000166199.9
|
Chn1
|
chimerin 1 |
chr14_-_70445086 | 5.32 |
ENSMUST00000022682.6
|
Sorbs3
|
sorbin and SH3 domain containing 3 |
chrX_+_7588453 | 5.26 |
ENSMUST00000043045.10
ENSMUST00000207386.2 ENSMUST00000116634.9 ENSMUST00000208072.2 ENSMUST00000207589.2 ENSMUST00000208618.2 ENSMUST00000208443.2 ENSMUST00000207541.2 ENSMUST00000208528.2 ENSMUST00000115689.10 ENSMUST00000131077.9 ENSMUST00000115688.8 ENSMUST00000208156.2 |
Wdr45
Gm45208
|
WD repeat domain 45 predicted gene 45208 |
chr2_+_136555364 | 5.23 |
ENSMUST00000028727.11
ENSMUST00000110098.4 |
Snap25
|
synaptosomal-associated protein 25 |
chr15_-_96918203 | 5.19 |
ENSMUST00000166223.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr10_-_5144699 | 5.18 |
ENSMUST00000215467.2
|
Syne1
|
spectrin repeat containing, nuclear envelope 1 |
chr1_-_184543367 | 5.13 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr2_-_64806106 | 5.08 |
ENSMUST00000156765.2
|
Grb14
|
growth factor receptor bound protein 14 |
chr12_+_38831093 | 5.07 |
ENSMUST00000161513.9
|
Etv1
|
ets variant 1 |
chr3_+_146276147 | 5.07 |
ENSMUST00000199489.5
|
Uox
|
urate oxidase |
chr8_+_24159669 | 5.06 |
ENSMUST00000042352.11
ENSMUST00000207301.2 |
Zmat4
|
zinc finger, matrin type 4 |
chr14_+_27598021 | 5.03 |
ENSMUST00000211684.2
ENSMUST00000210924.2 |
Erc2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr15_-_96917804 | 5.02 |
ENSMUST00000231039.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr11_+_110914678 | 4.98 |
ENSMUST00000150902.8
ENSMUST00000178798.2 |
Kcnj16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr6_+_121983720 | 4.95 |
ENSMUST00000081777.8
|
Mug2
|
murinoglobulin 2 |
chr12_-_84497718 | 4.88 |
ENSMUST00000085192.7
ENSMUST00000220491.2 |
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr14_-_104081827 | 4.83 |
ENSMUST00000022718.11
|
Ednrb
|
endothelin receptor type B |
chr3_+_54063459 | 4.82 |
ENSMUST00000029311.11
ENSMUST00000200048.5 |
Trpc4
|
transient receptor potential cation channel, subfamily C, member 4 |
chr15_-_12549963 | 4.82 |
ENSMUST00000189324.2
|
Pdzd2
|
PDZ domain containing 2 |
chr1_+_66426127 | 4.79 |
ENSMUST00000145419.8
|
Map2
|
microtubule-associated protein 2 |
chr11_+_114741948 | 4.75 |
ENSMUST00000133245.2
ENSMUST00000122967.3 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr10_+_111342147 | 4.69 |
ENSMUST00000164773.2
|
Phlda1
|
pleckstrin homology like domain, family A, member 1 |
chr12_-_103623418 | 4.65 |
ENSMUST00000044159.7
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr2_+_25293140 | 4.63 |
ENSMUST00000154809.8
ENSMUST00000055921.14 ENSMUST00000141567.8 |
Npdc1
|
neural proliferation, differentiation and control 1 |
chr2_-_71198091 | 4.61 |
ENSMUST00000151937.8
|
Slc25a12
|
solute carrier family 25 (mitochondrial carrier, Aralar), member 12 |
chr3_+_146302832 | 4.60 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr1_+_34275665 | 4.59 |
ENSMUST00000194192.3
|
Dst
|
dystonin |
chrX_+_7588505 | 4.56 |
ENSMUST00000207675.2
ENSMUST00000116633.9 ENSMUST00000208996.2 ENSMUST00000144148.4 ENSMUST00000125991.9 ENSMUST00000148624.8 |
Wdr45
|
WD repeat domain 45 |
chr2_+_25293056 | 4.52 |
ENSMUST00000071442.12
|
Npdc1
|
neural proliferation, differentiation and control 1 |
chr15_-_78352801 | 4.51 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr18_-_39051695 | 4.49 |
ENSMUST00000040647.11
|
Fgf1
|
fibroblast growth factor 1 |
chr5_-_104261556 | 4.45 |
ENSMUST00000031249.8
|
Sparcl1
|
SPARC-like 1 |
chr11_-_107238956 | 4.43 |
ENSMUST00000134763.2
|
Pitpnc1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr12_+_38830812 | 4.41 |
ENSMUST00000160856.8
|
Etv1
|
ets variant 1 |
chr13_-_78344492 | 4.34 |
ENSMUST00000125176.3
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1 |
chr17_+_43671314 | 4.31 |
ENSMUST00000226087.2
|
Adgrf5
|
adhesion G protein-coupled receptor F5 |
chr11_+_17001586 | 4.29 |
ENSMUST00000131515.2
|
Cnrip1
|
cannabinoid receptor interacting protein 1 |
chr18_+_51250748 | 4.23 |
ENSMUST00000116639.4
|
Prr16
|
proline rich 16 |
chr3_+_85946145 | 4.18 |
ENSMUST00000238331.2
|
Sh3d19
|
SH3 domain protein D19 |
chr9_-_99599312 | 4.14 |
ENSMUST00000112882.9
ENSMUST00000131922.2 |
Cldn18
|
claudin 18 |
chr10_+_29087658 | 4.08 |
ENSMUST00000213489.2
|
9330159F19Rik
|
RIKEN cDNA 9330159F19 gene |
chrX_+_100419965 | 4.06 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr17_+_70829050 | 4.06 |
ENSMUST00000133717.9
ENSMUST00000148486.8 |
Dlgap1
|
DLG associated protein 1 |
chr3_+_68491487 | 4.05 |
ENSMUST00000182997.3
|
Schip1
|
schwannomin interacting protein 1 |
chr1_+_34199333 | 4.04 |
ENSMUST00000183302.6
ENSMUST00000185897.7 ENSMUST00000185269.7 |
Dst
|
dystonin |
chr11_+_78389913 | 4.04 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr10_-_57408512 | 4.03 |
ENSMUST00000169122.8
|
Serinc1
|
serine incorporator 1 |
chr6_-_88851027 | 4.03 |
ENSMUST00000038409.12
|
Podxl2
|
podocalyxin-like 2 |
chr3_-_27950491 | 4.03 |
ENSMUST00000058077.4
|
Tmem212
|
transmembrane protein 212 |
chr11_+_78215026 | 4.00 |
ENSMUST00000102478.4
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr4_-_96479793 | 3.98 |
ENSMUST00000055693.9
|
Cyp2j9
|
cytochrome P450, family 2, subfamily j, polypeptide 9 |
chr12_+_84498196 | 3.97 |
ENSMUST00000137170.3
|
Lin52
|
lin-52 homolog (C. elegans) |
chr9_-_103099262 | 3.97 |
ENSMUST00000170904.2
|
Trf
|
transferrin |
chr16_+_33712305 | 3.96 |
ENSMUST00000232262.2
|
Itgb5
|
integrin beta 5 |
chr11_+_69657275 | 3.95 |
ENSMUST00000132528.8
ENSMUST00000153943.2 |
Zbtb4
|
zinc finger and BTB domain containing 4 |
chr16_+_17149235 | 3.94 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr7_+_19024994 | 3.93 |
ENSMUST00000108468.5
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr12_+_37292029 | 3.90 |
ENSMUST00000160390.2
|
Agmo
|
alkylglycerol monooxygenase |
chr5_-_87716882 | 3.89 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr1_-_171023798 | 3.86 |
ENSMUST00000111332.2
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr3_+_137923521 | 3.77 |
ENSMUST00000090171.7
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr14_+_55797934 | 3.75 |
ENSMUST00000121622.8
ENSMUST00000143431.2 ENSMUST00000150481.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chrM_+_3906 | 3.73 |
ENSMUST00000082396.1
|
mt-Nd2
|
mitochondrially encoded NADH dehydrogenase 2 |
chr6_+_108771840 | 3.71 |
ENSMUST00000204483.2
|
Arl8b
|
ADP-ribosylation factor-like 8B |
chr2_+_58644922 | 3.71 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr18_-_3281089 | 3.71 |
ENSMUST00000139537.2
ENSMUST00000124747.8 |
Crem
|
cAMP responsive element modulator |
chr5_-_104261285 | 3.71 |
ENSMUST00000199947.2
|
Sparcl1
|
SPARC-like 1 |
chr4_-_131565542 | 3.68 |
ENSMUST00000030741.9
ENSMUST00000105987.9 |
Ptpru
|
protein tyrosine phosphatase, receptor type, U |
chr5_+_90708962 | 3.68 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr7_+_44499005 | 3.68 |
ENSMUST00000150335.2
ENSMUST00000107882.8 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr13_-_98152768 | 3.66 |
ENSMUST00000238746.2
|
Arhgef28
|
Rho guanine nucleotide exchange factor (GEF) 28 |
chr9_+_50405817 | 3.66 |
ENSMUST00000114474.8
ENSMUST00000188047.2 |
Plet1
|
placenta expressed transcript 1 |
chr6_-_87365859 | 3.66 |
ENSMUST00000032127.6
|
Gkn3
|
gastrokine 3 |
chr17_-_43003135 | 3.64 |
ENSMUST00000170723.8
ENSMUST00000164524.2 ENSMUST00000024711.11 ENSMUST00000167993.8 |
Adgrf4
|
adhesion G protein-coupled receptor F4 |
chr5_+_25451771 | 3.64 |
ENSMUST00000144971.2
|
Galnt11
|
polypeptide N-acetylgalactosaminyltransferase 11 |
chr19_-_42074777 | 3.62 |
ENSMUST00000051772.10
|
Morn4
|
MORN repeat containing 4 |
chrX_-_20787150 | 3.61 |
ENSMUST00000081893.7
ENSMUST00000115345.8 |
Syn1
|
synapsin I |
chr8_+_31579499 | 3.60 |
ENSMUST00000036631.14
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr8_-_68658694 | 3.57 |
ENSMUST00000212960.2
|
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr2_+_148237258 | 3.56 |
ENSMUST00000109962.4
|
Sstr4
|
somatostatin receptor 4 |
chr13_+_60749995 | 3.55 |
ENSMUST00000044083.9
|
Dapk1
|
death associated protein kinase 1 |
chr1_-_169938298 | 3.51 |
ENSMUST00000192312.6
|
Ddr2
|
discoidin domain receptor family, member 2 |
chr11_+_68986043 | 3.50 |
ENSMUST00000101004.9
|
Per1
|
period circadian clock 1 |
chr14_+_33193765 | 3.50 |
ENSMUST00000208577.2
|
Frmpd2
|
FERM and PDZ domain containing 2 |
chr2_-_110144869 | 3.50 |
ENSMUST00000133608.2
|
Bbox1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
chr4_+_43383449 | 3.50 |
ENSMUST00000135216.2
ENSMUST00000152322.8 |
Rusc2
|
RUN and SH3 domain containing 2 |
chr10_-_57408585 | 3.50 |
ENSMUST00000020027.11
|
Serinc1
|
serine incorporator 1 |
chr6_-_5496261 | 3.47 |
ENSMUST00000203347.3
ENSMUST00000019721.7 |
Pdk4
|
pyruvate dehydrogenase kinase, isoenzyme 4 |
chr11_+_118324652 | 3.47 |
ENSMUST00000106286.3
|
C1qtnf1
|
C1q and tumor necrosis factor related protein 1 |
chr18_+_69477541 | 3.45 |
ENSMUST00000114985.10
ENSMUST00000128706.8 ENSMUST00000201781.4 ENSMUST00000202674.4 |
Tcf4
|
transcription factor 4 |
chr4_+_94627513 | 3.45 |
ENSMUST00000073939.13
ENSMUST00000102798.8 |
Tek
|
TEK receptor tyrosine kinase |
chr8_-_25066313 | 3.44 |
ENSMUST00000121992.2
|
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr7_+_18910340 | 3.44 |
ENSMUST00000117338.8
|
Eml2
|
echinoderm microtubule associated protein like 2 |
chr6_-_83808717 | 3.43 |
ENSMUST00000058383.9
|
Paip2b
|
poly(A) binding protein interacting protein 2B |
chr18_+_43897354 | 3.43 |
ENSMUST00000187157.7
ENSMUST00000043803.13 ENSMUST00000189750.2 |
Scgb3a2
|
secretoglobin, family 3A, member 2 |
chr6_+_14901343 | 3.42 |
ENSMUST00000115477.8
|
Foxp2
|
forkhead box P2 |
chr2_+_85715984 | 3.42 |
ENSMUST00000213441.3
|
Olfr1023
|
olfactory receptor 1023 |
chr13_-_63712349 | 3.41 |
ENSMUST00000192155.6
|
Ptch1
|
patched 1 |
chr8_+_96429665 | 3.41 |
ENSMUST00000073139.14
ENSMUST00000080666.8 ENSMUST00000212160.2 |
Ndrg4
|
N-myc downstream regulated gene 4 |
chr1_-_97904958 | 3.40 |
ENSMUST00000161567.8
|
Pam
|
peptidylglycine alpha-amidating monooxygenase |
chr10_-_67972401 | 3.40 |
ENSMUST00000218532.2
|
Arid5b
|
AT rich interactive domain 5B (MRF1-like) |
chr19_+_45003670 | 3.40 |
ENSMUST00000236377.2
|
Lzts2
|
leucine zipper, putative tumor suppressor 2 |
chr16_-_23339329 | 3.39 |
ENSMUST00000230040.2
ENSMUST00000229619.2 |
Masp1
|
mannan-binding lectin serine peptidase 1 |
chr17_+_79922329 | 3.38 |
ENSMUST00000040368.3
|
Rmdn2
|
regulator of microtubule dynamics 2 |
chr3_-_148696155 | 3.37 |
ENSMUST00000196526.5
ENSMUST00000200543.5 ENSMUST00000200154.5 |
Adgrl2
|
adhesion G protein-coupled receptor L2 |
chr10_+_29087602 | 3.35 |
ENSMUST00000092627.6
|
9330159F19Rik
|
RIKEN cDNA 9330159F19 gene |
chr18_+_45402018 | 3.35 |
ENSMUST00000183850.8
ENSMUST00000066890.14 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr7_-_27252543 | 3.34 |
ENSMUST00000127240.8
ENSMUST00000117095.8 ENSMUST00000117611.8 |
Pld3
|
phospholipase D family, member 3 |
chrX_+_55831887 | 3.33 |
ENSMUST00000144600.8
|
Fhl1
|
four and a half LIM domains 1 |
chr2_+_164328763 | 3.32 |
ENSMUST00000109349.9
|
Dbndd2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr11_-_107361525 | 3.32 |
ENSMUST00000103064.10
|
Pitpnc1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr19_-_40175709 | 3.30 |
ENSMUST00000051846.13
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr9_+_44951075 | 3.30 |
ENSMUST00000217097.2
|
Mpzl2
|
myelin protein zero-like 2 |
chr9_-_53882530 | 3.29 |
ENSMUST00000048409.14
|
Elmod1
|
ELMO/CED-12 domain containing 1 |
chr9_-_102231884 | 3.28 |
ENSMUST00000035129.14
ENSMUST00000085169.12 ENSMUST00000149800.3 |
Ephb1
|
Eph receptor B1 |
chr10_+_29019645 | 3.28 |
ENSMUST00000092629.4
|
Soga3
|
SOGA family member 3 |
chr15_+_8997480 | 3.27 |
ENSMUST00000227191.3
|
Ranbp3l
|
RAN binding protein 3-like |
chr7_-_141925947 | 3.27 |
ENSMUST00000084412.6
|
Ifitm10
|
interferon induced transmembrane protein 10 |
chr11_-_94390788 | 3.27 |
ENSMUST00000127305.2
|
Epn3
|
epsin 3 |
chr15_-_37792635 | 3.26 |
ENSMUST00000090150.11
ENSMUST00000150453.2 |
Ncald
|
neurocalcin delta |
chr1_-_130589349 | 3.25 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr11_+_70104929 | 3.24 |
ENSMUST00000094055.10
ENSMUST00000126296.8 ENSMUST00000136328.2 ENSMUST00000153993.3 |
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr14_+_40826970 | 3.24 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr1_-_22551594 | 3.23 |
ENSMUST00000239255.2
|
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr3_-_82957104 | 3.22 |
ENSMUST00000048246.5
|
Fgb
|
fibrinogen beta chain |
chr1_-_150268470 | 3.19 |
ENSMUST00000006167.13
ENSMUST00000097547.10 |
Odr4
|
odr4 GPCR localization factor homolog |
chr14_+_59716265 | 3.18 |
ENSMUST00000224893.2
|
Cab39l
|
calcium binding protein 39-like |
chr3_+_133942244 | 3.18 |
ENSMUST00000181904.3
|
Cxxc4
|
CXXC finger 4 |
chr14_-_70561231 | 3.17 |
ENSMUST00000151011.8
|
Slc39a14
|
solute carrier family 39 (zinc transporter), member 14 |
chr14_-_100522101 | 3.17 |
ENSMUST00000228216.2
|
Klf12
|
Kruppel-like factor 12 |
chr7_+_140343652 | 3.17 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr16_-_4698148 | 3.16 |
ENSMUST00000037843.7
|
Ubald1
|
UBA-like domain containing 1 |
chr15_+_25752963 | 3.15 |
ENSMUST00000022882.12
ENSMUST00000135173.8 |
Myo10
|
myosin X |
chr7_+_100435548 | 3.14 |
ENSMUST00000216021.2
|
Fam168a
|
family with sequence similarity 168, member A |
chr3_-_141637245 | 3.13 |
ENSMUST00000106232.8
|
Bmpr1b
|
bone morphogenetic protein receptor, type 1B |
chr1_+_88334678 | 3.13 |
ENSMUST00000027518.12
|
Spp2
|
secreted phosphoprotein 2 |
chr11_-_121279062 | 3.12 |
ENSMUST00000106107.3
|
Rab40b
|
Rab40B, member RAS oncogene family |
chr10_+_69761784 | 3.10 |
ENSMUST00000181974.8
ENSMUST00000182795.8 ENSMUST00000182437.8 |
Ank3
|
ankyrin 3, epithelial |
chr6_+_116627567 | 3.09 |
ENSMUST00000067354.10
ENSMUST00000178241.4 |
Depp1
|
DEPP1 autophagy regulator |
chr8_+_59365291 | 3.09 |
ENSMUST00000160055.2
|
BC030500
|
cDNA sequence BC030500 |
chr3_+_62245765 | 3.07 |
ENSMUST00000079300.13
|
Arhgef26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr8_-_85500010 | 3.06 |
ENSMUST00000109764.8
|
Nfix
|
nuclear factor I/X |
chr3_+_31956814 | 3.04 |
ENSMUST00000192429.6
ENSMUST00000191869.6 ENSMUST00000178668.2 ENSMUST00000119970.8 |
Kcnmb2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr4_+_57821050 | 3.04 |
ENSMUST00000238994.2
|
Pakap
|
paralemmin A kinase anchor protein |
chr17_+_70829144 | 3.04 |
ENSMUST00000140728.8
|
Dlgap1
|
DLG associated protein 1 |
chr1_-_130589321 | 3.04 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr10_-_89369432 | 3.03 |
ENSMUST00000105297.2
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr14_-_68893253 | 3.03 |
ENSMUST00000225767.3
ENSMUST00000111072.8 ENSMUST00000022642.6 ENSMUST00000224039.2 |
Adam28
|
a disintegrin and metallopeptidase domain 28 |
chr15_+_99290832 | 3.02 |
ENSMUST00000160635.8
ENSMUST00000161250.8 ENSMUST00000229392.2 ENSMUST00000161778.8 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr1_-_179373826 | 3.02 |
ENSMUST00000027769.6
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr18_-_60881679 | 2.99 |
ENSMUST00000237783.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr1_+_156443472 | 2.99 |
ENSMUST00000190749.2
|
Abl2
|
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
chr15_+_54975713 | 2.99 |
ENSMUST00000096433.10
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr17_+_17669082 | 2.95 |
ENSMUST00000140134.2
|
Lix1
|
limb and CNS expressed 1 |
chr5_-_70999547 | 2.95 |
ENSMUST00000199705.2
|
Gabrg1
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
chr1_+_172525613 | 2.94 |
ENSMUST00000038495.5
|
Crp
|
C-reactive protein, pentraxin-related |
chr3_-_31364500 | 2.94 |
ENSMUST00000091259.9
|
Slc7a14
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
chr9_-_48747232 | 2.93 |
ENSMUST00000093852.5
|
Zbtb16
|
zinc finger and BTB domain containing 16 |
chr1_+_57884693 | 2.93 |
ENSMUST00000169772.3
|
Spats2l
|
spermatogenesis associated, serine-rich 2-like |
chr11_+_17001818 | 2.93 |
ENSMUST00000058159.6
|
Cnrip1
|
cannabinoid receptor interacting protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 35.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.6 | 10.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.5 | 12.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
2.1 | 8.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.9 | 5.8 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 5.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
1.9 | 15.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.9 | 9.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.9 | 5.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.8 | 5.5 | GO:0009753 | sesquiterpenoid metabolic process(GO:0006714) response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.7 | 5.2 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
1.7 | 5.1 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
1.7 | 10.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.6 | 8.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.5 | 6.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.5 | 6.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.5 | 7.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 5.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.4 | 5.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.4 | 6.8 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
1.3 | 6.5 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.3 | 8.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.2 | 3.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
1.2 | 4.9 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.2 | 3.7 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.2 | 5.9 | GO:0010157 | response to chlorate(GO:0010157) |
1.2 | 4.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.2 | 3.5 | GO:0097037 | heme export(GO:0097037) |
1.1 | 3.4 | GO:0030573 | bile acid catabolic process(GO:0030573) |
1.1 | 6.7 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
1.1 | 3.3 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
1.1 | 3.2 | GO:0009087 | methionine catabolic process(GO:0009087) |
1.1 | 7.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.1 | 4.2 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.0 | 6.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.0 | 3.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.0 | 4.0 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.0 | 2.9 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.0 | 3.8 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.9 | 2.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.9 | 5.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 3.7 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.9 | 2.8 | GO:2000863 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) positive regulation of estrogen secretion(GO:2000863) |
0.9 | 8.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.9 | 3.6 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.9 | 7.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 3.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 2.6 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.8 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.8 | 10.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.8 | 2.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.8 | 3.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.8 | 7.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.8 | 4.8 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.8 | 2.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) negative regulation of neutrophil migration(GO:1902623) |
0.8 | 3.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.8 | 3.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.7 | 6.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.7 | 2.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.7 | 2.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.7 | 2.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.7 | 4.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 8.3 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.7 | 2.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.7 | 4.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 9.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.7 | 2.7 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.7 | 2.0 | GO:0072755 | cellular response to benomyl(GO:0072755) response to benomyl(GO:1901561) |
0.7 | 15.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 1.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 8.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 3.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.6 | 1.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.6 | 3.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 6.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 12.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.6 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 1.8 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 4.1 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.6 | 3.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 2.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.6 | 4.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 2.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.6 | 2.3 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 1.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 6.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 3.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 7.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 1.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.5 | 4.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 6.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 2.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 1.6 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.5 | 9.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 4.7 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.5 | 2.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 1.6 | GO:0001966 | thigmotaxis(GO:0001966) |
0.5 | 5.1 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 6.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 1.0 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.5 | 2.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 2.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 5.0 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.5 | 4.0 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 2.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 1.5 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 2.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 3.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.5 | 4.4 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 1.5 | GO:0032618 | interleukin-15 production(GO:0032618) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.5 | 1.5 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.5 | 4.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 4.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.5 | 1.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.5 | 9.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 6.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 1.4 | GO:0034201 | response to oleic acid(GO:0034201) |
0.5 | 10.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.5 | 3.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.4 | 2.2 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.4 | 2.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 2.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 1.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 5.7 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 0.9 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 1.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.4 | 3.4 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.4 | 5.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 3.4 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 2.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 3.4 | GO:0031179 | peptide modification(GO:0031179) |
0.4 | 1.3 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.4 | 1.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 3.7 | GO:0061709 | reticulophagy(GO:0061709) |
0.4 | 4.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 7.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 9.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.4 | 6.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 1.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.4 | 0.4 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.4 | 1.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 2.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.4 | 2.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.2 | GO:0021627 | olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
0.4 | 3.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.6 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.4 | 2.0 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.4 | 1.2 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.4 | 1.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.4 | 0.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.4 | 0.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 5.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 0.7 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 2.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 2.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.4 | 0.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 2.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.4 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 1.4 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.4 | 1.8 | GO:1900738 | psychomotor behavior(GO:0036343) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 3.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 1.7 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.3 | 3.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 4.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 4.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 3.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 2.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 2.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 7.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 10.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 2.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.0 | GO:0033189 | response to vitamin A(GO:0033189) |
0.3 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 1.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.3 | 1.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.3 | 2.2 | GO:0042938 | antibiotic transport(GO:0042891) dipeptide transport(GO:0042938) |
0.3 | 1.5 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.3 | 7.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.2 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.9 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 16.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 3.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.3 | 1.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.3 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 1.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 2.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 1.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 1.2 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 14.7 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.3 | 5.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 4.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 1.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 5.7 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.3 | 2.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 1.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.3 | 8.0 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 4.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 5.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.6 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.3 | 4.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.1 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 1.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 0.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 3.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 1.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 5.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 13.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 1.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 2.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.2 | 1.5 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 2.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 1.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.2 | 11.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 6.0 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.2 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.2 | 4.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 5.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 2.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 2.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 2.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 8.8 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.2 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.2 | 2.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.7 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.2 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 1.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.9 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 1.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 2.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 1.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.8 | GO:1903070 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 2.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 4.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 1.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.2 | 4.7 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 1.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.6 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.2 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 7.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.8 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.2 | 2.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.2 | 2.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 2.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 2.8 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.5 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 4.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 3.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 3.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 2.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 2.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 4.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.9 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 1.0 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 2.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 3.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 3.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.5 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 3.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 1.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 3.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.5 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.2 | 1.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.5 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.6 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.2 | 1.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 2.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 3.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 3.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 1.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 3.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.1 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 3.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 1.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 1.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 2.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 1.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 2.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 3.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 1.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 1.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 5.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.9 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 1.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 1.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 2.5 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.6 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 4.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 1.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 1.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 3.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 7.1 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 1.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 3.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.6 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 1.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 1.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.6 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 2.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.3 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.6 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 4.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.8 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 6.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.1 | 2.3 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 1.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 3.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 2.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 3.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 1.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.8 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 4.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.2 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.3 | GO:1904735 | negative regulation of electron carrier activity(GO:1904733) regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:1904735) negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:1904736) |
0.1 | 4.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 2.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 1.9 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 3.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.6 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.5 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.3 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.5 | GO:0071931 | Cajal body organization(GO:0030576) positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
0.1 | 1.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 1.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 3.8 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.1 | 3.0 | GO:0030815 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cAMP metabolic process(GO:0030815) |
0.1 | 3.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 2.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 1.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 3.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.8 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 1.8 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 2.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 3.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 1.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 4.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.1 | 3.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 5.7 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 1.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 1.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 1.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 2.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 5.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.1 | 3.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 9.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 2.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 2.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 1.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.4 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 4.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 1.6 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.1 | 0.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 3.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.5 | GO:1902855 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 1.9 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 4.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.5 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.2 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.1 | 0.8 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 1.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.3 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 3.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 1.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.0 | 2.0 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 1.4 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.4 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 5.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 1.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 1.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 1.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 3.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.0 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 1.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 2.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.0 | 1.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 1.2 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 2.5 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 2.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 2.6 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 34.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 1.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.6 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 1.8 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 1.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 3.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.6 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.4 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.0 | 1.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.4 | GO:0014802 | terminal cisterna(GO:0014802) |
1.2 | 9.8 | GO:0031673 | H zone(GO:0031673) |
1.2 | 9.3 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 3.5 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.1 | 3.3 | GO:0016014 | dystrobrevin complex(GO:0016014) |
1.0 | 5.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 3.1 | GO:0005712 | chiasma(GO:0005712) |
0.9 | 8.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 7.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 3.2 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.8 | 4.0 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.8 | 5.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 8.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 16.0 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 7.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 2.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.6 | 1.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 3.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 9.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 6.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.6 | GO:0043512 | inhibin A complex(GO:0043512) |
0.5 | 2.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 3.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.5 | 4.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.5 | 2.1 | GO:1902737 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
0.5 | 9.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 7.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.5 | 1.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.5 | 5.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 2.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.4 | 4.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 4.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 4.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 1.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 3.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 2.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.4 | 5.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 4.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 2.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 4.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.8 | GO:0070449 | elongin complex(GO:0070449) |
0.3 | 4.6 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 2.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 2.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 6.8 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 10.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 3.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 3.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 6.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 6.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.6 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.2 | 2.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 2.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 7.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 6.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 3.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 4.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 2.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.9 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.2 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 3.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 8.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 10.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.6 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 2.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 2.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 2.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 62.0 | GO:0014069 | postsynaptic density(GO:0014069) |
0.1 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 3.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 3.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.1 | 1.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 5.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 6.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 12.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 24.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.7 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 5.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 27.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 9.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 28.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 3.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 51.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 10.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 8.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 4.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 11.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 13.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 2.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 2.0 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 5.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.0 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 8.0 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 5.0 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 2.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 16.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 8.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 15.0 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 2.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 2.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 43.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 12.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 28.6 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.0 | 0.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 3.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 20.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 4.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.0 | GO:0035976 | AP1 complex(GO:0035976) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
2.3 | 6.9 | GO:0034632 | retinol transporter activity(GO:0034632) |
2.2 | 8.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.1 | 12.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.9 | 5.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.8 | 7.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.8 | 5.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.6 | 4.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.5 | 7.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.4 | 5.6 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.3 | 3.9 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
1.3 | 5.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 10.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.2 | 8.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.2 | 7.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 4.7 | GO:0005118 | sevenless binding(GO:0005118) |
1.1 | 3.4 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
1.1 | 8.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
1.1 | 3.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.1 | 6.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.1 | 6.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.1 | 4.2 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
1.0 | 3.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.0 | 12.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.0 | 21.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 3.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.9 | 6.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 10.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.9 | 2.7 | GO:0005333 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
0.9 | 3.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 3.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 2.5 | GO:0070905 | serine binding(GO:0070905) |
0.8 | 4.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 3.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.8 | 3.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 2.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.7 | 6.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 2.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 2.2 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.7 | 2.9 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.7 | 2.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.7 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 8.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.7 | 2.1 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
0.7 | 5.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 1.9 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.6 | 7.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 4.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.6 | 3.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 2.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.6 | 5.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 2.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.6 | 9.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 4.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 3.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.6 | 1.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.6 | 4.6 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 4.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.6 | 6.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 3.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.6 | 3.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 2.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 6.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.5 | 1.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.5 | 1.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.5 | 2.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.5 | 4.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 5.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 6.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 3.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 2.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 3.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 1.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 3.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 1.4 | GO:0019002 | GMP binding(GO:0019002) |
0.5 | 1.8 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.5 | 15.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 16.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 1.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.4 | 1.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.4 | 13.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 5.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 2.5 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.4 | 8.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 2.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.4 | 2.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 1.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 4.4 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 2.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 1.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.4 | 2.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 1.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.4 | 1.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 2.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 4.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 4.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 5.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.4 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.4 | 1.4 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 2.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 6.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.3 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 9.6 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 7.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 4.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 4.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 2.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.3 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.3 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 17.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 2.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.3 | 5.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 10.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.2 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.3 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 2.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.8 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 5.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 2.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 2.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 3.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 3.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 19.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 2.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 9.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 3.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 1.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 1.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 8.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 6.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 8.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 2.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 9.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 4.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.2 | 3.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 6.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 2.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 4.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 4.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.9 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 3.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 33.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 3.7 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 2.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 16.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 2.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 2.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 7.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 3.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 6.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 2.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 11.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 4.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 2.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 2.6 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 3.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 2.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.5 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.1 | 2.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 14.3 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 2.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 4.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 4.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 5.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 5.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 6.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 7.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 5.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 2.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 2.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 2.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 9.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 1.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 2.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 13.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 1.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 2.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 1.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 2.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.1 | 4.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 8.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 2.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 13.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 22.5 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 4.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 6.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 1.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 3.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 1.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 1.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 1.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0008823 | ferric-chelate reductase activity(GO:0000293) cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 2.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.3 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 5.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 1.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 5.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 14.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 19.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 18.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 12.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 3.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 23.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 15.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 8.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 14.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 7.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 9.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 9.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 9.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 3.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 5.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 7.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 7.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 5.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 8.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 8.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 4.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 12.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 13.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 4.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 2.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 8.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 2.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 10.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 3.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.0 | 15.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 11.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.9 | 15.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 1.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 7.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 8.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 11.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 10.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 9.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 7.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 3.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 6.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 15.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 5.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 9.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 7.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 7.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 14.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 5.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.3 | 3.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 5.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 3.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 7.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 8.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 4.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 5.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 8.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 7.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 5.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 13.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 7.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 2.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 9.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 4.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 3.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 4.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 3.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 5.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 4.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 13.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 5.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 5.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 5.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 20.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 7.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 4.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 5.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 4.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 3.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 9.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 2.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 3.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 2.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |